II
InnovoTEX Inc.
SEC filingBiotechnology · Austin, TX
Amount raised$75Ksold at filing
Total offering$75K
Investors in the raise2count reported to the SEC
FiledAug 18, 2026first sale Mar 9, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jonathan SesslerDirector
James HusseyDirector
Jonathan ArambulaDirector
Krystle KaroscikExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.